Docoh
Loading...

DBTX Decibel Therapeutics

News

From Benzinga Pro
Regeneron Extends Hearing Loss Gene Therapy pact With Decibel
22 Nov 21
Biotech, News, Health Care, Contracts, General
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has
HC Wainwright & Co. Initiates Coverage On Decibel Therapeutics with Buy Rating, Announces Price Target of $23
15 Nov 21
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Decibel Therapeutics (NASDAQ:DBTX) with a Buy rating and announces Price Target of $23.
SVB Leerink Maintains Outperform on Decibel Therapeutics, Lowers Price Target to $14
10 Nov 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Mani Foroohar maintains Decibel Therapeutics (NASDAQ:DBTX) with a Outperform and lowers the price target from $15 to $14.
Watch Brilliant Earth, Landos Biopharma, Decibel Therapeutics Following TipRanks Article '3 "Strong Buy" Small-Cap Stocks With Plenty of Upside'
28 Oct 21
Media, Trading Ideas
https://www.tipranks.com/news/article/159057-2
Baird Initiates Coverage On Decibel Therapeutics with Outperform Rating, Announces Price Target of $21
22 Oct 21
News, Price Target, Initiation, Analyst Ratings
Baird analyst Jack Allen initiates coverage on Decibel Therapeutics (NASDAQ:DBTX) with a Outperform rating and announces Price Target of $21.
Decibel Therapeutics to Present at the Jefferies Gene Therapy/Editing Summit
20 Oct 21
News, Events
Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laurence Reid,
Decibel Therapeutics Announces Publication Of Foundational Study Of Noise-related Inner Ear Damage
30 Sep 21
News, FDA, Events
Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that findings from
Decibel Therapeutics' Hearing Loss Gene Therapy Receives FDA Orphan Drug Tag
9 Sep 21
Biotech, News, Health Care, FDA, Movers, Trading Ideas, General
Decibel Therapeutics Receives Orphan Drug And Rare Pediatric Disease Designations For DB-OTO For The Treatment Of Otoferlin-Related Congenital Hearing Loss
9 Sep 21
News, FDA
Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that the U.S.

Press releases

From Benzinga Pro
Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss
22 Nov 21
News, Press Releases
Collaboration gene therapy product candidate, DB-OTO, on track to enter clinical testing in 2022; two additional gene therapy programs for congenital, monogenic forms of hearing loss in development under the
Decibel Therapeutics to Present at the Jefferies Gene Therapy/Editing Summit
20 Oct 21
News, Health Care, Press Releases
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and
Decibel Therapeutics Announces Publication of Foundational Study of Noise-related Inner Ear Damage
30 Sep 21
Health Care, Press Releases
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
9 Sep 21
Health Care, Press Releases
BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and